Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
VASC [NASD]
Vascular Solutions Inc.
Index- P/E39.27 EPS (ttm)0.70 Insider Own3.40% Shs Outstand17.18M Perf Week4.60%
Market Cap472.28M Forward P/E29.88 EPS next Y0.92 Insider Trans-0.68% Shs Float16.38M Perf Month14.02%
Income12.20M PEG1.96 EPS next Q0.20 Inst Own58.80% Short Float2.83% Perf Quarter10.85%
Sales117.70M P/S4.01 EPS this Y8.30% Inst Trans0.09% Short Ratio7.45 Perf Half Y19.21%
Book/sh6.21 P/B4.43 EPS next Y21.05% ROA11.10% Target Price27.50 Perf Year39.68%
Cash/sh2.10 P/C13.12 EPS next 5Y20.00% ROE12.50% 52W Range18.35 - 28.23 Perf YTD18.75%
Dividend- P/FCF33.03 EPS past 5Y-8.40% ROI11.60% 52W High-2.62% Beta0.00
Dividend %- Quick Ratio4.90 Sales past 5Y12.50% Gross Margin66.90% 52W Low49.81% ATR0.86
Employees406 Current Ratio6.20 Sales Q/Q12.00% Oper. Margin16.60% RSI (14)74.77 Volatility3.57% 3.44%
OptionableYes Debt/Eq0.00 EPS Q/Q5.90% Profit Margin10.40% Rel Volume0.88 Prev Close27.33
ShortableYes LT Debt/Eq0.00 EarningsOct 21 AMC Payout0.00% Avg Volume62.25K Price27.49
Recom1.70 SMA206.18% SMA5011.31% SMA20015.95% Volume54,839 Change0.59%
12-Dec-13Reiterated Feltl & Co. Buy $21 → $23
23-Oct-13Reiterated Feltl & Co. Buy $18.75 → $21
06-Feb-13Reiterated Feltl & Co. Buy $16.25 → $18.75
06-Feb-13Reiterated Canaccord Genuity Buy $18.75 → $20.50
06-Feb-13Downgrade The Benchmark Company Buy → Hold $17
22-Oct-12Reiterated Feltl & Co. Buy $15.25 → $16.25
02-Oct-12Reiterated The Benchmark Company Buy $15 → $17
08-May-12Initiated The Benchmark Company Buy $15
25-Apr-12Upgrade Dougherty & Company Neutral → Buy $11.50 → $12.50
23-Jul-10Reiterated Feltl & Co. Buy $12 → $14.50
24-Jun-10Initiated Stifel Nicolaus Buy $16
04-Mar-10Initiated Wedbush Morgan Outperform $12
21-Oct-09Reiterated Caris & Company Above Average $9 → $10
21-May-09Initiated Caris & Company Above Average $9
05-Feb-08Reiterated Canaccord Adams Buy $14 → $11
20-Jul-07Initiated RBC Capital Mkts Outperform
05-Apr-07Initiated Sun Trust Rbsn Humphrey Buy $13
31-Jan-07Reiterated Feltl & Co. Buy $12 → $14
21-Oct-14 05:31PM  Vascular Solutions posts 3Q profit AP
04:21PM  VASCULAR SOLUTIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online
04:05PM  Vascular Solutions Reports Third Quarter Results GlobeNewswire
07:07AM  Q3 2014 Vascular Solutions Inc Earnings Release - After Market Close CCBN
02-Oct-14 04:05PM  Vascular Solutions, Inc. to Webcast Third Quarter Conference Call GlobeNewswire
31-Jul-14 06:03AM  VASCULAR SOLUTIONS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
30-Jul-14 05:29PM  Vascular Solutions Announces Settlement of Patent Lawsuit With Boston Scientific GlobeNewswire
04:05PM  Vascular Solutions to Present at the 34th Annual Canaccord Genuity Growth Conference GlobeNewswire
29-Jul-14 01:04PM  VASCULAR SOLUTIONS INC Financials EDGAR Online Financials
28-Jul-14 05:04PM  Vascular Solutions Comments on Justice Department Press Release Concerning Qui Tam Lawsuit Settlement Agreement GlobeNewswire
23-Jul-14 02:06PM  Decoding 4 Stocks' Big Earnings Moves at Motley Fool +10.18%
22-Jul-14 04:24PM  VASCULAR SOLUTIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online
04:05PM  Vascular Solutions Reports Second Quarter Results GlobeNewswire
07:07AM  Q2 2014 Vascular Solutions, Inc. Earnings Release - After Market Close CCBN
03-Jul-14 05:04PM  Vascular Solutions announces recall of Langston catheters theflyonthewall.com
04:05PM  Vascular Solutions, Inc. Issues Recall of Langston(R) Dual Lumen Catheters GlobeNewswire
01-Jul-14 04:05PM  Vascular Solutions, Inc. to Webcast Second Quarter Conference Call GlobeNewswire
19-Jun-14 04:05PM  Vascular Solutions Launches Gel-Bead(TM) Embolization Spheres GlobeNewswire
21-May-14 07:10AM  Vascular Solutions (VASC) Falls: Stock Goes Down 5.3% Zacks
02-May-14 06:53AM  What Makes Vascular Solutions (VASC) a Strong Sell? Zacks
01-May-14 04:35PM  VASCULAR SOLUTIONS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
04:05PM  Vascular Solutions to Participate in Bank of America Merrill Lynch 2014 Health Care Conference GlobeNewswire
22-Apr-14 09:50PM  Vascular Solutions' CEO Discusses Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
04:30PM  Vascular Solutions, Inc. Earnings Call scheduled for 4:30 pm ET today CCBN
04:29PM  VASCULAR SOLUTIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online
04:17PM  Vascular Solutions enters into agreement with U.S. Army at theflyonthewall.com
04:05PM  Vascular Solutions Reports First Quarter Results GlobeNewswire
04:03PM  Vascular Solutions Enters Into Agreement With U.S. Army to Develop Freeze-Dried Plasma Product GlobeNewswire
07:07AM  Q1 2014 Vascular Solutions, Inc. Earnings Release - After Market Close CCBN
16-Apr-14 05:50PM  Injunction Lifted on Boston Scientific's Guidezilla Zacks
15-Apr-14 01:03PM  [$$] Court Lifts Injunction Against Boston Scientific at The Wall Street Journal
12:40PM  Injunction lifted on Boston Scientific catheter product Reuters
11:50AM  Preliminary Injunction Against Boston Scientific's Guidezilla(TM) Catheter Vacated by Federal Circuit GlobeNewswire
11:36AM  Injunction lifted on Boston Scientific catheter product Guidezilla Reuters
09-Apr-14 04:05PM  Vascular Solutions Surpasses 50,000 Successfully Reprocessed ClosureFAST(R) Catheters GlobeNewswire
08-Apr-14 04:05PM  Vascular Solutions, Inc. to Webcast First Quarter Conference Call GlobeNewswire
20-Feb-14 04:33PM  VASCULAR SOLUTIONS INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
19-Feb-14 04:30PM  Physician Reports Positive 12-Month Clinical Experience and Cost Savings From Use of Reprocessed ClosureFAST(R) Catheters GlobeNewswire
04-Feb-14 10:54PM  Vascular Solutions' CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
04:30PM  Vascular Solutions, Inc. Earnings Call scheduled for 4:30 pm ET today CCBN
04:23PM  VASCULAR SOLUTIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online
04:05PM  Vascular Solutions Reports Record Fourth Quarter Results GlobeNewswire
07:07AM  Q4 2013 Vascular Solutions, Inc. Earnings Release - After Market Close CCBN
21-Jan-14 09:00AM  Vascular Solutions Launches ThrombiDisc(TM) Topical Hemostat in U.S. GlobeNewswire
14-Jan-14 07:42PM  The Story Is Working For AngioDynamics at Seeking Alpha
13-Jan-14 09:00AM  Preliminary Injunction Against Boston Scientific's Guidezilla(TM) Catheter Becomes Effective GlobeNewswire
07-Jan-14 04:05PM  Vascular Solutions, Inc. to Webcast Fourth Quarter Conference Call GlobeNewswire
11-Dec-13 04:05PM  Vascular Solutions Receives Shonin Approvals to Launch GuideLiner(R) Catheter and SuperCross(TM) FT Microcatheter in Japan GlobeNewswire
09-Dec-13 06:02PM  Vascular Solutions Granted Preliminary Injunction Against Boston Scientific's Guidezilla(TM) Catheter GlobeNewswire
26-Nov-13 04:05PM  Vascular Solutions to Present at the 25th Annual Piper Jaffray Health Care Conference GlobeNewswire
18-Nov-13 06:07PM  Vascular Solutions' Management Presents at Barclays Select Growth Conference (Transcript) at Seeking Alpha
04-Nov-13 04:05PM  Vascular Solutions to Present at the Barclays Select Growth Conference GlobeNewswire
30-Oct-13 04:05PM  Vascular Solutions to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum GlobeNewswire
22-Oct-13 10:14PM  Vascular Solutions' CEO Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha
04:30PM  Vascular Solutions, Inc. Earnings Call scheduled for 4:30 pm ET today CCBN
04:26PM  VASCULAR SOLUTIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online
04:25PM  Vascular Solutions, Inc. Discusses Q3 2013 Results (Webcast) at Seeking Alpha
04:05PM  Vascular Solutions Reports Third Quarter Results GlobeNewswire
07:07AM  Q3 2013 Vascular Solutions, Inc. Earnings Release - After Market Close CCBN
03-Oct-13 04:30PM  Vascular Solutions, Inc. to Webcast Third Quarter Conference Call GlobeNewswire
16-Sep-13 04:05PM  Vascular Solutions Surpasses 30,000 Successfully Reprocessed ClosureFAST(R) Catheters GlobeNewswire
28-Aug-13 04:05PM  Vascular Solutions to Present at the 2013 Stifel Nicolaus Healthcare Conference GlobeNewswire
23-Aug-13 10:06AM  Why Vascular Solutions Is Poised to Outperform at Motley Fool
31-Jul-13 04:05PM  Vascular Solutions to Present at the 33rd Annual Canaccord Genuity Growth Conference GlobeNewswire
26-Jul-13 09:20AM  This Metric Suggests You're Right to Own Vascular Solutions. at Motley Fool
23-Jul-13 07:15PM  Vascular Solutions, Inc. (VASC) CEO Discusses Q2 2013 Results - Earnings Call Transcript at Seeking Alpha
06:55PM  Vascular Solutions Earnings: Heres Why Investors are Excited Now at Wall St. Cheat Sheet
04:15PM  InPlay: Vascular Solutions reports EPS in-line, beats on revs; guides Q3 EPS in-line, revs in-line; reaffirms FY13 EPS guidance, raises bottom end of FY13 revs in-line Briefing.com
04:05PM  Vascular Solutions Reports Second Quarter Results GlobeNewswire
09:22AM  VASCULAR SOLUTIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online
07:07AM  Q2 2013 Vascular Solutions, Inc. Earnings Release - After Market Close CCBN
22-Jul-13 08:55PM  Vascular Solutions Earnings Preview: Can This Streak Continue? at Wall St. Cheat Sheet
19-Jul-13 01:40AM  Will Vascular Solutions Beat These Analyst Estimates? at Motley Fool
02-Jul-13 04:05PM  Vascular Solutions, Inc. to Webcast Second Quarter Conference Call on Tuesday, July 23rd at 3:30pm CDT GlobeNewswire
Vascular Solutions, Inc., a medical device company, provides various solutions to interventional cardiologists, interventional radiologists, electro physiologists, and vein practices worldwide. The company's catheter products include GuideLiner catheters for deep-seating, back-out support, and optimal stenting in various interventions; Pronto extraction catheters for treating acute myocardial infarction; Micro-Introducers for performing arterial and venous catheterization procedures; Langston to measure intravascular pressure gradients for the diagnosis of aortic valve stenosis; and SmartNeedle, a doppler-guided needle device designed to provide auditory ultrasound-guided access to arteries and veins. It also offers Venture, a deflectable tip catheter used for steering guidewires in various interventions; Guardian, a hemostat valve used in catheterization procedures; SuperCross, a microcatheter for support and delivery of guidewires during coronary and peripheral catheterization procedures; Snares to retrieve or manipulate objects in the cardiovascular system; and Minnie, a support catheter used to facilitate placement and exchange of guidewires and other interventional devices. In addition, the company provides hemostat products comprising D-Stat Dry Thrombix, a thrombin-based hemostat bandage used to control bleeding at the site of femoral artery punctures; D-Stat Flowable, a flowable mixture to control bleeding in the pectoral pockets; Vasc Band radial hemostat, a compression device used to assist with bleeding control; D-Stat Radial, a wrist band to control bleeding at the radial artery access site; and accumed wrist positioning splint. Further, it offers vein products and services, such as Vari-Lase endovenous laser, a laser console and procedure kit used for the treatment of varicose veins, as well as a reprocessing service for the ClosureFAST radiofrequency vein ablation catheter. The company was founded in 1996 and is headquartered in Minneapolis, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Slayton TimothyPrincipal Accounting OfficerApr 24Sale23.151,39032,1799,265Apr 28 04:15 PM
HENNEN JAMESSr. VP of Finance and CFOFeb 27Sale25.255,554140,23950,151Feb 28 04:06 PM
HENNEN JAMESSr. VP of Finance and CFOFeb 26Sale25.634,446113,95155,705Feb 28 04:06 PM
ROOT HOWARDChief Executive OfficerFeb 25Option Exercise9.4648,000454,080493,990Feb 26 04:16 PM
NIGON RICHARDDirectorFeb 25Buy25.661,00025,66058,187Feb 27 04:16 PM
ROOT HOWARDChief Executive OfficerFeb 25Sale24.7048,0001,185,600445,990Feb 26 04:16 PM
ROOT HOWARDChief Executive OfficerFeb 24Option Exercise9.462,00018,920447,990Feb 26 04:16 PM
ROOT HOWARDChief Executive OfficerFeb 24Sale25.612,00051,220445,990Feb 26 04:16 PM
NIGON RICHARDDirectorFeb 20Option Exercise10.8910,000108,90065,187Feb 24 04:13 PM
NIGON RICHARDDirectorFeb 20Sale25.188,000201,44057,187Feb 24 04:13 PM
ROOT HOWARDChief Executive OfficerFeb 14Option Exercise9.463,59534,009449,585Feb 18 04:05 PM
ROOT HOWARDChief Executive OfficerFeb 14Sale24.513,59588,113445,990Feb 18 04:05 PM
ROOT HOWARDChief Executive OfficerFeb 13Option Exercise9.4621,405202,491467,395Feb 18 04:05 PM
ROOT HOWARDChief Executive OfficerFeb 13Sale25.2321,405540,134445,990Feb 18 04:05 PM
O'CONNELL PAULDirectorFeb 11Sale24.432,00048,8604,687Feb 13 10:31 AM
RUTSTEIN WILLIAMSr. VP of Worldwide SalesFeb 10Sale23.7011,666276,48438,425Feb 11 11:19 AM
RUTSTEIN WILLIAMSr. VP of Worldwide SalesFeb 07Sale23.8816,116384,85050,091Feb 11 11:19 AM
ERB JOHN LDirectorNov 08Option Exercise7.8830,000236,50027,985Nov 12 04:31 PM
HENNEN JAMESSr. VP of Finance and CFONov 08Sale19.5815,000293,68556,883Nov 12 04:33 PM
ERB JOHN LDirectorNov 08Sale19.4930,000584,5707,985Nov 12 04:31 PM
ERB JOHN LDirectorNov 07Option Exercise10.3920,000207,70017,985Nov 12 04:31 PM
ERB JOHN LDirectorNov 07Sale19.3820,000387,5207,985Nov 12 04:31 PM
HENNEN JAMESSr. VP of Finance and CFOOct 28Option Exercise9.462,43122,99774,177Oct 29 04:27 PM
HENNEN JAMESSr. VP of Finance and CFOOct 28Sale19.722,43147,93271,746Oct 29 04:27 PM